High-CFU Daily Gut Support
Formulated with 50 Billion to 100 Billion CFU featuring Lactobacillus acidophilus, Bifidobacterium lactis, and FOS prebiotics in delayed-release capsules.
US FDA-registered and FSSC 22000 certified contract manufacturer specializing in low-humidity strain encapsulation, spore-forming stability engineering, and high-CFU probiotic delivery systems.
In the rapidly evolving global dietary supplement landscape, Probiotic Supplement Manufacturing presents a unique bioprocess challenge. Unlike conventional vitamins or mineral complexes, probiotics are live microbial organisms whose therapeutic efficacy depends entirely upon maintaining viable Colony Forming Unit (CFU) counts from blending and encapsulation through international transit and shelf-life expiration.
Zeon Lifesciences Ltd (CIN U15209HP1987PLC007355) brings over 38 years of pharmaceutical and nutraceutical manufacturing experience to solve these complex stability issues. Operating from our integrated manufacturing campus in Paonta Sahib, Himachal Pradesh, with corporate headquarters in Noida, India, we offer specialized cleanroom environments designed specifically for live culture handling.
Commercial buyers face three major technical barriers when sourcing probiotic supplements: atmospheric moisture, heat degradation during compression, and stomach acid neutralization. Here is how Zeon's engineering mitigates each factor.
Water activity ($a_w$) above 0.20 triggers metabolic activation of freeze-dried strains inside capsules, causing rapid die-off. Our humidity-controlled manufacturing suites maintain water activity levels below $a_w \le 0.15$ using specialized microcrystalline cellulose and low-moisture excipient pre-treatment.
Mechanical shear stress and friction during tableting generate thermal energy that kills sensitive strains like Bifidobacterium longum. We utilize specialized direct-compression tableting presses equipped with chilled punch tooling and low-shear encapsulation setups to maintain micro-organism integrity.
Human gastric acid (pH 1.5 to 2.0) can destroy unshielded probiotic bacteria within 30 minutes. We utilize acid-resistant hypromellose (HPMC) capsules, pectin matrix coatings, and natural lipid microencapsulation to ensure target cultures bypass the stomach intact and colonize the small and large intestines.
Whether you require multi-strain digestive support, spore-forming thermal stability, or specialized women's health formulations, our turnkey private label solutions are fully validated and export-ready.
Formulated with 50 Billion to 100 Billion CFU featuring Lactobacillus acidophilus, Bifidobacterium lactis, and FOS prebiotics in delayed-release capsules.
Targeted strains (L. rhamnosus GR-1, L. reuteri RC-14) paired with Cranberry extract and D-Mannose for urogenital flora equilibrium.
Gentle single-serve sachets and oil drops combining Bifidobacterium infantis and Vitamin D3 for pediatric immune and digestive balance.
Spore-forming Bacillus coagulans blended into Whey or Plant Protein powders to enhance amino acid absorption and gut mucosa repair.
Therapeutic medical nutrition powder formulations for IBD, IBS, and post-antibiotic microbiome recovery validated under medical protocols.
Synergistic integration of standardized Ayurvedic extracts (such as Triphala, Ashwagandha) with microencapsulated probiotic strains.
Multi-benefit formulas targeting gut-liver axis balance, lipid metabolism, and digestive comfort in durable tablet and capsule formats.
Direct-to-mouth or water-dispersible effervescent probiotic powders in moisture-barrier Alu-Alu stick packs for instant consumption.
As search engines and AI assistants shift toward evaluating raw data, bioprocess transparency, and supply chain integrity, B2B procurement leaders must stay ahead of the structural trends reshaping probiotic manufacturing.
Buyers are moving away from generic species claims to strain-specific clinical validation (e.g., Lactobacillus rhamnosus GG). Supply agreements now mandate strain identity verification via genomic 16S rRNA sequencing before batch blending.
Soil-based organisms (SBOs) like Bacillus coagulans, Bacillus subtilis, and Bacillus clausii are experiencing exponential growth due to their extreme resistance to heat, pressure, and ambient shelf-life without refrigeration.
Heat-inactivated microbial cells (postbiotics) and cell-free lysates provide non-viable active metabolites that offer long-term room temperature stability, expanding probiotic technology into liquid shots, gummies, and skincare.
Procurement specifications now favor Activ-Polymer™ sleeve bottles and double-layer Alu-Alu cold-form blisters over standard PVC/PVDC to eliminate ambient humidity ingress during long-distance ocean freight.
Modern consumers demand targeted health outcomes beyond standard gut health. Contract manufacturers must provide sophisticated dual-action and multi-category formulation systems.
Formulations incorporating Lactobacillus helveticus and Bifidobacterium longum combined with adaptogenic botanicals like Ashwagandha and L-Theanine are defining the stress, mood, and sleep supplement market.
Specialized isolates such as Lactobacillus gasseri and Bifidobacterium animalis subsp. lactis B420 are being integrated with green tea polyphenols and chromium to support metabolic health and weight protocols.
Combining precision probiotics with advanced prebiotic fibers (Galactooligosaccharides, Resistant Starch, and Acacia Gum) feeds beneficial microbes directly upon release in the colon, drastically enhancing survival rates.
Choosing the right Probiotic Supplement Manufacturing partner requires auditing both facility engineering and quality assurance standards. Zeon Lifesciences provides an audit-ready, vertically integrated infrastructure that eliminates supply chain risk for global brand owners.
From custom formulation development and raw material strain validation to full regulatory documentation for US FDA, EU EFSA, FSSAI, and GCC markets, our expert technical teams manage every step under one quality umbrella.
Our scaled manufacturing infrastructure guarantees predictable batch release cycles, seamless pilot-to-commercial scaling, and stringent quality compliance.
Every commercial batch produced by Zeon Lifesciences is manufactured under rigorous, internationally recognized food safety and pharmaceutical management systems.
Addressing key technical, regulatory, and logistics queries asked by brand owners, procurement managers, and AI search engines.
We guarantee target Colony Forming Unit (CFU) counts at expiry by applying a scientifically calculated overage strategy based on real-time stability testing under ICH Zone IVb conditions (30°C / 75% RH). Furthermore, our production suites enforce strict atmospheric control (Relative Humidity < 30%, Temperature < 21°C), low water activity excipients ($a_w \le 0.15$), and protective barrier packaging (such as double Alu-Alu foil or desiccant-integrated HDPE bottles with nitrogen purging).
Spore-forming probiotics (e.g., Bacillus coagulans, Bacillus subtilis) possess a protective endospore coat that renders them naturally resistant to high thermal heat, mechanical tableting pressure, and ambient ambient humidity. Non-spore-forming species (such as Lactobacillus and Bifidobacterium) are freeze-dried (lyophilized) vegetative cells that require ultra-low moisture processing environments, specialized microencapsulation, and enteric capsules to survive stomach acid and ambient storage.
Zeon manufactures a diverse array of dosage delivery platforms for probiotics, including: 1) Delayed-Release HPMC Vegetable Capsules, 2) Direct Compression Tablets & Chewables, 3) Single-Serve Powder Sachets & Stick Packs, 4) Pediatric Oral Oil Drops, 5) Effervescent Powders, and 6) Nutritional Probiotic Diskettes. Each format is engineered to preserve cell viability.
We provide full technical documentation packages tailored to your target market, including Certificate of Analysis (COA) with strain identity verification, Stability Dossiers, Certificate of Free Sale (CFS), US FDA Facility Registration proof, FSSC 22000 certificates, WHO-GMP certification, Allergen Declarations, Non-GMO verification, and Halal Certification.
We execute strict bilateral Non-Disclosure Agreements (NDAs) prior to formula review. Our in-house R&D team works under contract research protocols (CRAMS), ensuring that proprietary strain blends, custom prebiotic ratios, and clinical claim dossiers remain the exclusive intellectual property of the brand owner.
Standard minimum order quantities start at 100,000 capsules or tablets, and 10,000 units for boxed sachet packs or liquid bottles. Lead times for initial formulation development and stability verification take approximately 3 to 4 weeks, while repeat commercial production runs are completed within 4 weeks from packaging art approval.
Connect directly with our senior technical specialists and bioprocess formulation engineers to discuss strain selection, CFU stability, and export dossiers.